LSTA
Lisata Therapeutics Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$28.59M
P/E Ratio
—
EPS
$-1.86
Beta
0.81
52W High
$5.07
52W Low
$1.81
50-Day MA
$4.00
200-Day MA
$3.10
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
2.71
PEG Ratio
118.40
About Lisata Therapeutics Inc.
Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing and commercializing cellular therapies to reverse disease and/or promote regeneration of damaged tissue. The company is headquartered in Basking Ridge, New Jersey.
Fundamentals
| Revenue (TTM) | 170,000 |
| Gross Profit (TTM) | 170,000 |
| EBITDA | $-17.20M |
| Operating Margin | -10179.00% |
| Return on Equity | -91.40% |
| Return on Assets | -50.30% |
| Revenue/Share (TTM) | $0.02 |
| Book Value | $1.20 |
| Price-to-Book | 2.66 |
| Price-to-Sales (TTM) | 168.20 |
| EV/Revenue | 41.92 |
| EV/EBITDA | 0.82 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -90.00% |
| Shares Outstanding | $9.11M |
| Float | $7.19M |
| % Insiders | 20.89% |
| % Institutions | 11.43% |
Historical Volatility
HV 10-Day
43.56%
HV 20-Day
44.62%
HV 30-Day
94.46%
HV 60-Day
80.98%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($4.00 target)
1
Strong Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026